Hi. On your marketing question. First, need to remember who we will be marketing to - the physicians. In that sense you could say marketing activities are already happening and have been for a while. For example, we have an excellent advisory board, and we present at all the leading conferences. One great thing is there aren't 1000s and 1000s of places to reach, the TAVR centres number in the 100s, so logistically it is not the most complex exercise. Our advisory board accounts for something like 20-25% of the market, they are all enthusiastic supporters of DurAVR, so we will pick up market share very quickly once approvals come through
AVR Price at posting:
$21.10 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)